Title: Multidrug‐resistant <i>Trichophyton rubrum</i> in a 67‐year‐old female patient with tinea corporis
Abstract: Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR Multidrug-resistant Trichophyton rubrum in a 67-year-old female patient with tinea corporis Carolin Xander, Carolin Xander orcid.org/0009-0003-9203-1401 Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSearch for more papers by this authorMaya Wolfensperger, Maya Wolfensperger Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSearch for more papers by this authorIngo Haase, Ingo Haase Hautspezialisten am Glattpark, Glattpark (Opfikon), SwitzerlandSearch for more papers by this authorPhilipp P. Bosshard, Corresponding Author Philipp P. Bosshard [email protected] orcid.org/0000-0002-1154-2281 Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland Correspondence Philipp P. Bosshard, Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Email: [email protected]Search for more papers by this author Carolin Xander, Carolin Xander orcid.org/0009-0003-9203-1401 Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSearch for more papers by this authorMaya Wolfensperger, Maya Wolfensperger Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSearch for more papers by this authorIngo Haase, Ingo Haase Hautspezialisten am Glattpark, Glattpark (Opfikon), SwitzerlandSearch for more papers by this authorPhilipp P. Bosshard, Corresponding Author Philipp P. Bosshard [email protected] orcid.org/0000-0002-1154-2281 Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland Correspondence Philipp P. Bosshard, Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Email: [email protected]Search for more papers by this author First published: 31 October 2023 https://doi.org/10.1111/jdv.19594Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Open Research DATA AVAILABILITY STATEMENT Data sharing is not applicable to this article as no new data were created or analysed in this study. REFERENCES 1Zaias N, Rebell G. Chronic dermatophytosis caused by Trichophyton rubrum. J Am Acad Dermatol. 1996; 35: 17–20. 10.1016/S0190-9622(96)90065-1 CASPubMedWeb of Science®Google Scholar 2Kano R, Kimura U, Noguchi H, Hiruma M. Clinical isolate of a multi-antifungal-resistant Trichophyton rubrum. Antimicrob Agents Chemother. 2022; 66:e02393-21. 10.1128/aac.02393-21 PubMedWeb of Science®Google Scholar 3Monod M, Feuermann M, Salamin K, Fratti M, Makino M, Alshahni MM, et al. Trichophyton rubrum azole resistance mediated by a new ABC transporter, TruMDR3. Antimicrob Agents Chemother. 2019; 63:e00863-19. 10.1128/AAC.00863-19 PubMedWeb of Science®Google Scholar 4Klinger M, Theiler M, Bosshard PP. Epidemiological and clinical aspects of Trichophyton mentagrophytes/Trichophyton interdigitale infections in the Zurich area: a retrospective study using genotyping. J Eur Acad Dermatol Venereol. 2021; 35: 1017–1025. 10.1111/jdv.17106 CASPubMedWeb of Science®Google Scholar 5Curatolo R, Juricevic N, Leong C, Bosshard PP. Antifungal susceptibility testing of dermatophytes: development and evaluation of an optimised broth microdilution method. Mycoses. 2021; 64: 282–291. 10.1111/myc.13202 CASPubMedWeb of Science®Google Scholar 6 The European Committee on Antimicrobial Susceptibility Testing. Overview of antifungal ECOFFs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST E.Def 7.3, E.Def 9.4 and E.Def 11.0 procedures. Version 3. 2022. Available from: http://www.eucast.org Accessed 15 Aug 2023. Google Scholar 7Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, et al. Expert consensus on the management of dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018; 18: 1–11. 10.1186/s12895-018-0073-1 PubMedWeb of Science®Google Scholar 8Sardana K, Gupta A. Rational for drug dosimetry and duration of terbinafine in the context of recalcitrant dermatophytosis: is 500 mg better than 250 mg OD or BD? Indian J Dermatol. 2017; 62: 665–667. 10.4103/ijd.IJD_435_17 PubMedWeb of Science®Google Scholar 9Saunte DML, Pereiro-Ferreirós M, Rodríguez-Cerdeira C, Sergeev AY, Arabatzis M, Prohić A, et al. Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. J Eur Acad Dermatol Venereol. 2021; 35: 1582–1586. 10.1111/jdv.17241 CASPubMedWeb of Science®Google Scholar 10Singh A, Masih A, Monroy-Nieto J, Singh PK, Bowers J, Travis J, et al. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: genomic insights and resistance profile. Fungal Genet Biol. 2019; 133:103266. 10.1016/j.fgb.2019.103266 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
Publication Year: 2023
Publication Date: 2023-11-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot